We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
From its first use 3,4,-methylenedioxymethamphetamine (MDMA) has been recognised as a drug with therapeutic potential. Research on its clinical utility stopped when it entered the recreational drug scene but has slowly resurrected in the past decade. Currently there is enough evidence for MDMA to be removed from its Schedule 1 status of ‘no medical use’ and moved into Schedule 2 (alongside other misused but useful medicines such as heroin and amphetamine). Such a regulatory move would liberate its use as a medicine for patients experiencing severe mental illnesses such as treatment-resistant post-traumatic stress disorder.
To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.
To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
* Views captured on Cambridge Core between 2nd January 2018 - 15th August 2018. This data will be updated every 24 hours.
Rani Pathania, doctor
06 February 2015
Amphetamine ,methylphenidate, Morphine ,heroin, ketamine are all potential drugs used clinically but whenever we hear the word "MDMA" -The first though that comes in our mind is Ecstasy and Rave parties ,people behaving in odd manner and experiencing hallucination, paranoia and disinhibition. Recently there has been lot of discussion on use of MDMA intreatment of resistant PTSD ,illness that is one the psychiatric illness that very difficult to treat and getting common these days because all horrific stuff happening around us . Studies like Mithoefer et al. (2010) {2012) have found that 83% of the subjects receiving MDMA-assisted psychotherapy in a pilot study no longer met the criteria for PTSD, and every patient who received a placebo and then went on to receive MDMA-assisted psychotherapy experienced significant and lasting improvements.We are still in initial stage and only few studies have been done but results of these studies are very significant. More research in this is needed and government needs to contribute by moving it to schedule 2 lists of drugs so that more researchcan be done in this field. At the same time one has to be very careful andvigilant to make these drugs legal for therapeutic use looking into dependence risk, effect on memory, depression and chances of psychosis. More research is needed especially to look at possible harms of the drugs.It will bring more responsibility on clinician to prescribe and monitor drugs like this.Making these drugs legal is not easy but at it has happened in the past otherwise people with terminal cancer will still be suffering with pain and agony in last days of their life, people with ADHD will be suffering despite being capable of doing everything.Legalising it for therapeutic use is not only going to be beneficial for patients but also going to be beneficial for economy looking into burden and resources we use in treating resistant PTSD.
... More
Conflict of interest: None declared
Write a replyBack to top